Dr Mike Hardman obtained his BMedSci and MBChB from Sheffield University. He trained in General Medicine (MRCP) and Clinical Pharmacology in Sheffield, Munich and Oxford, conducted basic research at the MRC Unit and University Department of Clinical Pharmacology at the Radcliffe Infirmary, Oxford. He was awarded his MD from the University of Sheffield. After 10 years of clinical practice and research he joined ICI Pharmaceuticals.
For 28 years he has worked in all stages of drug development across several therapeutic areas in the UK, USA, Germany and Japan. He is currently VP IMI Collaborations AstraZeneca IMED.
He is a Fellow of the UK Faculty of Pharmaceutical Medicine, Coordinator of the IMI European Medicines Research Training Network (EMTRAIN) and was previously co-coordinator of the IMI PharmaTrain project. He is a member of the editorial board of the Journal of Medicines Development Sciences, lecturer at the EUDIPHARM Masters course in Lyon, and an external examiner at Basel University.